PROVIDER PROFILE · NPI 1902086770

John Koleth

Psychiatry & NeurologyRiverside, CAI

MEDICARE UTILIZATION · PART B · 2024

No data available for this provider in 2024.

PRESCRIBING · PART D · 2024

Total Rx claims

1,248

Beneficiaries

—

Total drug cost

$309K

Distinct drugs

Brand share

27.2%

Top prescribed drugs

Divalproex Sodium116 claims

Buspirone Hcl94 claims

Gabapentin80 claims

Venlafaxine Hcl80 claims

Olanzapine79 claims

QUALITY · MIPS · 2024

No data available for this provider in 2024.

INDUSTRY PAYMENTS · OPEN PAYMENTS · 2024

Total received

$71

Payment records

By payment type

Education$71

REFERRAL NETWORK

Where John Koleth's patients come from & go

Directional shared-patient flow from Medicare claims — who sends patients to this provider (inbound) and where this provider's patients go next (outbound). 5 inbound referrers · 0 outbound destinations.

Receives referrals from

Inbound — who sends patients here

Physician	Patients	Visits
GREATER PHILADELPHIA HEALTH ACTION, INC	54	213
GREATER PHILADELPHIA HEALTH ACTION INC.	35	120
Parkway Clinical Laboratories, Inc. Clinical Laboratory · Bensalem, PA	27	62
Quest Diagnostics Clinical Laboratories Inc Clinical Laboratory · Norristown, PA	17	26
THOMAS JEFFERSON UNIVERSITY HOSPITALS INC	13	24

Refers patients to

Outbound — where patients go next

No outbound pairs above the suppression threshold.

Source: CMS Physician Shared Patient Patterns (30-day window, Medicare FFS). Direction = a beneficiary seen by the first provider, then the second, within 30 days; a proxy for referral, not a documented referral. Pairs with fewer than 11 shared beneficiaries are suppressed.

CROSS-REFERENCE

Related data on other Healthparse brands

ProviderScore

OIG/SAM exclusion screening, sanctions history